Related references
Note: Only part of the references are listed.The role of body fat in multiple sclerosis susceptibility and severity: A Mendelian randomisation study
Mona M. Almramhi et al.
MULTIPLE SCLEROSIS JOURNAL (2022)
An atlas on risk factors for multiple sclerosis: a Mendelian randomization study
Shuai Yuan et al.
JOURNAL OF NEUROLOGY (2021)
Investigating genetically mimicked effects of statins via HMGCR inhibition on immune-related diseases in men and women using Mendelian randomization
Guoyi Yang et al.
SCIENTIFIC REPORTS (2021)
Large-scale cis- and trans-eQTL analyses identify thousands of genetic loci and polygenic scores that regulate blood gene expression
Urmo Vosa et al.
NATURE GENETICS (2021)
Bioinformatic analysis of RHO family of GTPases identifies RAC1 pharmacological inhibition as a new therapeutic strategy for hepatocellular carcinoma
Juan Bayo et al.
GUT (2021)
Lipid Lowering and Alzheimer Disease Risk: A Mendelian Randomization Study
Dylan M. Williams et al.
ANNALS OF NEUROLOGY (2020)
Exploiting horizontal pleiotropy to search for causal pathways within a Mendelian randomization framework
Yoonsu Cho et al.
NATURE COMMUNICATIONS (2020)
The Effect of Plasma Lipids and Lipid-Lowering Interventions on Bone Mineral Density: A Mendelian Randomization Study
Jie Zheng et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2020)
Evaluating the relationship between circulating lipoprotein lipids and apolipoproteins with risk of coronary heart disease: A multivariable Mendelian randomisation analysis
Tom G. Richardson et al.
PLOS MEDICINE (2020)
Lipoprotein profiling in early multiple sclerosis patients: effect of chronic inflammation?
Zofia Radikova et al.
LIPIDS IN HEALTH AND DISEASE (2020)
The GTEx Consortium atlas of genetic regulatory effects across human tissues
Francois Aguet et al.
SCIENCE (2020)
Applying causal models to explore the mechanism of action of simvastatin in progressive multiple sclerosis
Arman Eshaghi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility
Nikolas A. Patsopoulos et al.
SCIENCE (2019)
Mevastatin promotes healing by targeting caveolin-1 to restore EGFR signaling
Andrew P. Sawaya et al.
JCI INSIGHT (2019)
Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course
Devon S. Conway et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Identification of the miRNA-mRNA regulatory network in multiple sclerosis
Qinghe Yang et al.
NEUROLOGICAL RESEARCH (2017)
Influence of hypertension, diabetes, hyperlipidemia, and obstructive lung disease on multiple sclerosis disease course
Devon S. Conway et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Mendelian randomisation in cardiovascular research: an introduction for clinicians
Derrick A. Bennett et al.
HEART (2017)
Correction: Orienting the causal relationship between imprecisely measured traits using GWAS summary data
Gibran Hemani et al.
PLoS Genetics (2017)
Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies
James Hrastelj et al.
JOURNAL OF NEUROLOGY (2017)
Combining information on multiple instrumental variables in Mendelian randomization: comparison of allele score and summarized data methods
Stephen Burgess et al.
STATISTICS IN MEDICINE (2016)
Assessing the suitability of summary data for two-sample Mendelian randomization analyses using MR-Egger regression: the role of the I2 statistic
Jack Bowden et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2016)
Regulating Rho GTPases and their regulators
Richard G. Hodge et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
Cholesterol and markers of cholesterol turnover in multiple sclerosis: relationship with disease outcomes
Simon Zhornitsky et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Atorvastatin reduces long pentraxin 3 expression in vascular cells by inhibiting protein geranylgeranylation
Roberta Baetta et al.
VASCULAR PHARMACOLOGY (2015)
An adverse lipid profile is associated with disability and progression in disability, in people with MS
Prudence Tettey et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Discovery and refinement of loci associated with lipid levels
Cristen J. Willer et al.
NATURE GENETICS (2013)
Rac2-Deficiency Leads to Exacerbated and Protracted Colitis in Response to Citrobacter rodentium Infection
Ramzi Fattouh et al.
PLOS ONE (2013)
Deciphering the signaling networks underlying simvastatin-induced apoptosis in human cancer cells: evidence for non-canonical activation of RhoA and Rac1 GTPases
Y. Zhu et al.
CELL DEATH & DISEASE (2013)
Rac2 expression and its role in neutrophil functions of zebrafish (Danio rerio)
Rachel M. Tell et al.
FISH & SHELLFISH IMMUNOLOGY (2012)
Statin therapy and multiple sclerosis disability in a population-based cohort
M. Mateo Paz Soldan et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Serum lipid profiles are associated with disability and MRI outcomes in multiple sclerosis
Bianca Weinstock-Guttman et al.
JOURNAL OF NEUROINFLAMMATION (2011)
An Evolutionary Analysis of RAC2 Identifies Haplotypes Associated with Human Autoimmune Diseases
Manuela Sironi et al.
MOLECULAR BIOLOGY AND EVOLUTION (2011)
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
Stephen Sawcer et al.
NATURE (2011)
Pleiotropic effects of statin therapy: molecular mechanisms and clinical results
Chao-Yung Wang et al.
TRENDS IN MOLECULAR MEDICINE (2008)
Cutting edge: Rac GTPases sensitize activated T Cells to die via Fas
Madhu Ramaswamy et al.
JOURNAL OF IMMUNOLOGY (2007)
Statins-treatment option for central nervous system autoimmune disease?
Martin S. Weber et al.
NEUROTHERAPEUTICS (2007)
Modulation of COX-2 expression by statins in human monocytic cells
Aida Habib et al.
FASEB JOURNAL (2007)
Statin therapy and autoimmune disease: from protein prenylation to immunomodulation
J Greenwood et al.
NATURE REVIEWS IMMUNOLOGY (2006)
Rho GTPases, statins, and nitric oxide
Y Rikitake et al.
CIRCULATION RESEARCH (2005)
Superoxide anion overproduction in sepsis: effects of vitamin E and simvastatin
R Durant et al.
SHOCK (2004)
Therapeutic potential of lovastatin in multiple sclerosis
A Sena et al.
JOURNAL OF NEUROLOGY (2003)
Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors
M Takemoto et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)